Extended Anticoagulation Therapy for the Primary and Secondary Prevention of Venous Thromboembolism

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.3, 2005-01, pp. : 303-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticoagulant effects of Idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trials

By Harenberg Job

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 555-563

Springer Publishing Company

Access to resources Recommend Favorite

Enoxaparin: In the Prevention of Venous Thromboembolism in Medical Patients

By Warner G.T. Perry C.M.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 477-481

Adis International

Access to resources Recommend Favorite

Fondaparinux versus enoxaparin for the prevention of venous thromboembolism

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 455-457

Informa Healthcare

Access to resources Recommend Favorite

The safety of fondaparinux for the prevention and treatment of venous thromboembolism

By Turpie Alexander GG

Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. : 707-721

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Prevention of Venous Thromboembolism in Medical Patients at Risk

By Wolozinsky Mia Yavin Yshai Y. Cohen Alexander T.

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 409-415

Adis International

Access to resources Recommend Favorite